Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to assess and compare
the safety and tolerability, as assessed by adverse events after multiple subcutaneous doses
of NN9535 in healthy male Japanese and Caucasian subjects.